华东医药(000963.SZ)：子公司收到医疗器械注册申请受理通知书

Core Viewpoint - Huadong Medicine (000963.SZ) announced that its wholly-owned subsidiary, Xinkelimeixue (Hangzhou) Medical Technology Co., Ltd., received the Acceptance Notice from the National Medical Products Administration (NMPA) for its Class III medical device registration application for lidocaine injection cross-linked hyaluronic acid gel MaiLiPrecise [1] Group 1 - The application for MaiLiPrecise has been accepted by NMPA, indicating progress in regulatory approval [1] - MaiLi series products are high-end hyaluronic acid gel products owned by Sinclair Pharmaceuticals Limited, a wholly-owned subsidiary of the company [1] - The products are developed in collaboration with Kylane Laboratoires SA, a Swiss professional medical aesthetics R&D company, in which Sinclair holds a stake [1]